reference/12102372

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12102372

Outgoing Links

Predicate	Object
contentType	Case Reports\|Letter
endingPage	e134
issn	1592-8721 0390-6078
issueIdentifier	4
pageRange	e133-e134
publicationName	Haematologica
startingPage	e133
bibliographicCitation	Duployez N, Grzych G, Ducourneau B, Alarcon Fuentes M, Grardel N, Boyer T, Abou Chahla W, Bruno B, Nelken B, Clappier E, Preudhomme C. NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors. Haematologica. 2016 Apr;101(4):e133–4. PMID: 26681761; PMCID: PMC5004396.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf9691e37f5924785cdfc536032fabb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3bf0654c805e4dd7aca22f4a4d4c6842 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8079e1615a5787d337f8d52ab5a23f6f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be9ad47c9d366a5aa5c75dc840e4fdc3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_835ec0451d145767fb42aa9cf2ec71d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4226516625a2ed6695b103f6be9a64ff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d77f06969dc1e73f16595f91d9be15d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1048-1517 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5844c23df16ece85ede7d1bb32ba89dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbe3a63fda961fe9678000aa1f72090f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df9ca08735e4dea1fd48f8a8e6df4b0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11c02374a59776ed01e6064a039fbcf6
date	2015-12-17^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC5004396 https://doi.org/10.3324/haematol.2015.136499 https://pubmed.ncbi.nlm.nih.gov/26681761
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3942 https://portal.issn.org/resource/ISSN/1592-8721 https://portal.issn.org/resource/ISSN/0390-6078
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors
discusses	http://id.nlm.nih.gov/mesh/M0023875 http://id.nlm.nih.gov/mesh/M0024934 http://id.nlm.nih.gov/mesh/M0383353 http://id.nlm.nih.gov/mesh/M0227868 http://id.nlm.nih.gov/mesh/M0457532
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D028861Q000235 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D015452Q000235 http://id.nlm.nih.gov/mesh/D016026 http://id.nlm.nih.gov/mesh/D015452Q000628 http://id.nlm.nih.gov/mesh/D016315Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D028861Q000378 http://id.nlm.nih.gov/mesh/D015514 http://id.nlm.nih.gov/mesh/D015452Q000473 http://id.nlm.nih.gov/mesh/D014185 http://id.nlm.nih.gov/mesh/D017211 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D001402Q000378 http://id.nlm.nih.gov/mesh/D001402Q000187 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001402Q000473 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D015870 http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D012074 http://id.nlm.nih.gov/mesh/D016315Q000378 http://id.nlm.nih.gov/mesh/D015452Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_82ba8a3344a65df669bf50c21d86dd60 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472a53b1a4ec3818b8392773f5523355 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043

Showing number of triples: 1 to 64 of 64.